Peptide TYACFVSNL is capable of eliciting CTL lines that lyse tumor cells expressing HLA-A24 and CEA. This is a HLA-A24 restricted epitope derived from carcinoembryonic antigen peptide (CEA). Nukaya, I. et al., Int. J. Cancer, 80, 92 (1999).
M.W.: 1017.17
